BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16165354)

  • 1. Structure-based design of 7-carbamate analogs of geldanamycin.
    Rastelli G; Tian ZQ; Wang Z; Myles D; Liu Y
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5016-21. PubMed ID: 16165354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of novel 17-aminogeldanamycin derivatives.
    Tian ZQ; Liu Y; Zhang D; Wang Z; Dong SD; Carreras CW; Zhou Y; Rastelli G; Santi DV; Myles DC
    Bioorg Med Chem; 2004 Oct; 12(20):5317-29. PubMed ID: 15388159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered biosynthesis of geldanamycin analogs for Hsp90 inhibition.
    Patel K; Piagentini M; Rascher A; Tian ZQ; Buchanan GO; Regentin R; Hu Z; Hutchinson CR; McDaniel R
    Chem Biol; 2004 Dec; 11(12):1625-33. PubMed ID: 15610846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Hsp90 dimerization modulators.
    Chiosis G; Aguirre J; Nicchitta CV
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3529-32. PubMed ID: 16621545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90.
    Jez JM; Chen JC; Rastelli G; Stroud RM; Santi DV
    Chem Biol; 2003 Apr; 10(4):361-8. PubMed ID: 12725864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inside the Hsp90 inhibitors binding mode through induced fit docking.
    Lauria A; Ippolito M; Almerico AM
    J Mol Graph Model; 2009 Feb; 27(6):712-22. PubMed ID: 19084447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in antitumor activity of the hsp90 inhibitor geldanamycin].
    Liao ZY; Zhen YS
    Yao Xue Xue Bao; 2001 Sep; 36(9):716-20. PubMed ID: 12580116
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotinylated geldanamycin.
    Clevenger RC; Raibel JM; Peck AM; Blagg BS
    J Org Chem; 2004 Jun; 69(13):4375-80. PubMed ID: 15202892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety.
    Lee D; Lee K; Cai XF; Dat NT; Boovanahalli SK; Lee M; Shin JC; Kim W; Jeong JK; Lee JS; Lee CH; Lee JH; Hong YS; Lee JJ
    Chembiochem; 2006 Feb; 7(2):246-8. PubMed ID: 16381049
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin.
    Lee YS; Marcu MG; Neckers L
    Chem Biol; 2004 Jul; 11(7):991-8. PubMed ID: 15271357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
    Onuoha SC; Mukund SR; Coulstock ET; Sengerovà B; Shaw J; McLaughlin SH; Jackson SE
    J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR backbone assignment of the N-terminal domain of human HSP90.
    Jacobs DM; Langer T; Elshorst B; Saxena K; Fiebig KM; Vogtherr M; Schwalbe H
    J Biomol NMR; 2006; 36 Suppl 1():52. PubMed ID: 16821127
    [No Abstract]   [Full Text] [Related]  

  • 14. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
    Chiosis G; Caldas Lopes E; Solit D
    Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural-thermodynamic relationships of interactions in the N-terminal ATP-binding domain of Hsp90.
    Nilapwar S; Williams E; Fu C; Prodromou C; Pearl LH; Williams MA; Ladbury JE
    J Mol Biol; 2009 Oct; 392(4):923-36. PubMed ID: 19631219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.
    Stebbins CE; Russo AA; Schneider C; Rosen N; Hartl FU; Pavletich NP
    Cell; 1997 Apr; 89(2):239-50. PubMed ID: 9108479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR chemical shift perturbation study of the N-terminal domain of Hsp90 upon binding of ADP, AMP-PNP, geldanamycin, and radicicol.
    Dehner A; Furrer J; Richter K; Schuster I; Buchner J; Kessler H
    Chembiochem; 2003 Sep; 4(9):870-7. PubMed ID: 12964162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 90 regulates development in Dictyostelium discoideum.
    Sawarkar R; Roy N; Rao S; Raman S; Venketesh S; Suguna K; Tatu U
    J Mol Biol; 2008 Oct; 383(1):24-35. PubMed ID: 18718841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a red-shifted fluorescence polarization probe for Hsp90.
    Moulick K; Clement CC; Aguirre J; Kim J; Kang Y; Felts S; Chiosis G
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4515-8. PubMed ID: 16797988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reaction of geldanamycin and C17-substituted analogues with glutathione: product identifications and pharmacological implications.
    Cysyk RL; Parker RJ; Barchi JJ; Steeg PS; Hartman NR; Strong JM
    Chem Res Toxicol; 2006 Mar; 19(3):376-81. PubMed ID: 16544941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.